N. Eche

498 total citations
25 papers, 361 citations indexed

About

N. Eche is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N. Eche has authored 25 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N. Eche's work include Venous Thromboembolism Diagnosis and Management (5 papers), Genetic factors in colorectal cancer (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). N. Eche is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (5 papers), Genetic factors in colorectal cancer (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). N. Eche collaborates with scholars based in France and United States. N. Eche's co-authors include Jean‐Marc Riedinger, J P Basuyau, Piérre Siè, B Boneu, M. Pichon, K. Hacène, Gabriel Ricolleau, C. Caranobe, A Boneu and Jean‐Pierre Armand and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and British Journal of Haematology.

In The Last Decade

N. Eche

21 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Eche France	11	113	95	71	63	61	25	361
Faruk Taş Türkiye	15	235 2.1×	31 0.3×	154 2.2×	54 0.9×	99 1.6×	44	585
Christopher J. Darus United States	13	166 1.5×	207 2.2×	164 2.3×	35 0.6×	93 1.5×	27	598
Nozomi Shinohara Japan	10	97 0.9×	62 0.7×	298 4.2×	55 0.9×	150 2.5×	17	482
Vibeke Jensen Denmark	11	234 2.1×	15 0.2×	91 1.3×	93 1.5×	36 0.6×	16	474
Kiyoaki Inoue Japan	5	61 0.5×	33 0.3×	285 4.0×	58 0.9×	68 1.1×	9	524
Mustafa Yaylacı Türkiye	10	187 1.7×	12 0.1×	49 0.7×	30 0.5×	49 0.8×	28	413
Fulvio Brema Italy	12	388 3.4×	31 0.3×	79 1.1×	36 0.6×	67 1.1×	36	562
Louis‐Joseph Auguste United States	10	177 1.6×	25 0.3×	40 0.6×	170 2.7×	123 2.0×	19	478
Shan Zheng China	13	271 2.4×	40 0.4×	106 1.5×	60 1.0×	103 1.7×	41	482

Countries citing papers authored by N. Eche

Since Specialization

Citations

This map shows the geographic impact of N. Eche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Eche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Eche more than expected).

Fields of papers citing papers by N. Eche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Eche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Eche. The network helps show where N. Eche may publish in the future.

Co-authorship network of co-authors of N. Eche

This figure shows the co-authorship network connecting the top 25 collaborators of N. Eche. A scholar is included among the top collaborators of N. Eche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Eche. N. Eche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pichon, Marie-France, G Brun, K. Hacène, et al.. (2009). Comparison of fifteen immunoassays for the measurement of serum MUC-1/CA 15-3 in breast cancer patients. Clinical Chemistry and Laboratory Medicine (CCLM). 47(8). 985–92. 10 indexed citations

Eche, N., et al.. (2009). Cinétique de PSA après radiothérapie. Annales de biologie clinique. 67(4). 395–404. 1 indexed citations

Riedinger, Jean‐Marc, et al.. (2008). Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: A French multicentric study. Gynecologic Oncology. 109(2). 194–198. 23 indexed citations

Eche, N., et al.. (2008). Cinétique du PSA après prostatectomie totale. Annales de biologie clinique. 67(1). 39–46.

Bonnetain, Franck, et al.. (2007). Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcome. Annals of Oncology. 18(5). 881–885. 30 indexed citations

Riedinger, Jean‐Marc, Gabriel Ricolleau, N. Eche, et al.. (2006). CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study. Annals of Oncology. 17(8). 1234–1238. 82 indexed citations

Courbon, F., Slimane Zerdoud, D. Bastié, et al.. (2006). Defective Efficacy of Retinoic Acid Treatment in Patients with Metastatic Thyroid Carcinoma. Thyroid. 16(10). 1025–1031. 30 indexed citations

Eche, N.. (2004). Marqueurs des cancers digestifs : côlon–rectum, pancréas, foie. Immuno-analyse & Biologie Spécialisée. 19(5). 279–285. 2 indexed citations

Basuyau, J P, M P Blanc-Vincent, Jean‐Michel Bidart, et al.. (2003). Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000. British Journal of Cancer. 89(S1). S32–S34. 9 indexed citations

10.

Riedinger, Jean‐Marc, N. Eche, J P Basuyau, et al.. (2002). [Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles].. PubMed. 60(2). 183–91. 1 indexed citations

11.

Eche, N., M. Pichon, Véronique Quillien, et al.. (2001). [Standards, options and recommendations for tumor markers in colorectal cancer].. PubMed. 88(12). 1177–206. 14 indexed citations

12.

Eche, N., et al.. (2001). Évaluation analytique et clinique des marqueurs tumoraux Vitros ECi™. Immuno-analyse & Biologie Spécialisée. 16(5). 324–337.

13.

Basuyau, J P, M P Blanc-Vincent, Jean‐Michel Bidart, et al.. (2000). [Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group].. PubMed. 87(10). 723–37. 16 indexed citations

14.

Jozan, S., et al.. (1991). 65 and 47 kDa forms of estrogen receptor in human breast cancer: relation with estrogen responsiveness. Breast Cancer Research and Treatment. 19(2). 103–109. 12 indexed citations

15.

Eche, N., et al.. (1986). Platelet aggregating and procoagulant activities of cultured human breast cancer cells (FAM). Thrombosis Research. 43(1). 121–127. 5 indexed citations

16.

Douste‐Blazy, P, Piérre Siè, B Boneu, et al.. (1984). Exercise-Induced Platelet Activation in Myocardial Infarction Survivors with Normal Coronary Arteriogram. Thrombosis and Haemostasis. 52(3). 297–300. 20 indexed citations

17.

Boneu, B, et al.. (1984). Exhausted platelets in patients with malignant solid tumors without evidence of active consumption coagulopathy. European Journal of Cancer and Clinical Oncology. 20(7). 899–903. 29 indexed citations

18.

Boneu, B, et al.. (1983). Platelet density analysis: a tool for the detection of acquired storage pool disease in man. British Journal of Haematology. 55(3). 523–532. 4 indexed citations

19.

Boneu, B, et al.. (1983). Platelet density analysis: a tool for the detection of acquired storage pool disease in man. British Journal of Haematology. 55(3). 523–532. 9 indexed citations

20.

Eche, N., Piérre Siè, C. Caranobe, et al.. (1981). Platelets in Myeloproliferative Disorders. III: Glycoprotein Profile in Relation to Platelet Function and Platelet Density. Scandinavian Journal of Haematology. 26(2). 123–129. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact